CIS: Market for Medicaments Containing Corticosteroid Hormones 2024

Market Size for Medicaments Containing Corticosteroid Hormones in CIS

The CIS medicaments containing corticosteroid hormones market fell to $X in 2022, dropping by X% against the previous year. The market value increased at an average annual rate of X% over the period from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The level of consumption peaked at $X in 2019; however, from 2020 to 2022, consumption failed to regain momentum.

Production of Medicaments Containing Corticosteroid Hormones in CIS

In value terms, medicaments containing corticosteroid hormones production reduced to $X in 2022 estimated in export price. Over the period under review, production continues to indicate a deep contraction. The most prominent rate of growth was recorded in 2015 when the production volume increased by X%. As a result, production reached the peak level of $X. From 2016 to 2022, production growth failed to regain momentum.

Join Us at HANNOVER MESSE 2024

Don’t miss your chance to connect with us directly. Schedule a personal meeting to dive deeper into how solutions.
Hall 002, Stand C10. 22 - 26 April 2024 | Hannover, Germany

Book Your Meeting

Exports of Medicaments Containing Corticosteroid Hormones

Exports in CIS

In 2022, overseas shipments of medicaments containing corticosteroid hormones decreased by X% to X tons, falling for the second consecutive year after four years of growth. Overall, exports, however, recorded a relatively flat trend pattern. The most prominent rate of growth was recorded in 2020 when exports increased by X% against the previous year. As a result, the exports attained the peak of X tons. From 2021 to 2022, the growth of the exports failed to regain momentum.

In value terms, medicaments containing corticosteroid hormones exports shrank rapidly to $X in 2022. Over the period under review, exports recorded a abrupt decline. The pace of growth appeared the most rapid in 2018 when exports increased by X% against the previous year. Over the period under review, the exports attained the peak figure at $X in 2012; however, from 2013 to 2022, the exports failed to regain momentum.

Exports by Country

Russia prevails in exports structure, resulting at X tons, which was near X% of total exports in 2022. It was distantly followed by Moldova (X tons), constituting a X% share of total exports. The following exporters - Uzbekistan (X tons), Armenia (X tons) and Kazakhstan (X tons) - together made up X% of total exports.

Russia experienced a relatively flat trend pattern with regard to volume of exports of medicaments containing corticosteroid hormones. At the same time, Uzbekistan (X%), Moldova (X%) and Armenia (X%) displayed positive paces of growth. Moreover, Uzbekistan emerged as the fastest-growing exporter exported in the CIS, with a CAGR of X% from 2012-2022. Kazakhstan experienced a relatively flat trend pattern. From 2012 to 2022, the share of Moldova, Uzbekistan and Armenia increased by X, X and X percentage points, while the shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Russia ($X) remains the largest medicaments containing corticosteroid hormones supplier in the CIS, comprising X% of total exports. The second position in the ranking was held by Moldova ($X), with a X% share of total exports. It was followed by Kazakhstan, with a X% share.

In Russia, medicaments containing corticosteroid hormones exports declined by an average annual rate of X% over the period from 2012-2022. In the other countries, the average annual rates were as follows: Moldova (X% per year) and Kazakhstan (X% per year).

Export Prices by Country

The export price in the CIS stood at $X per ton in 2022, which is down by X% against the previous year. Overall, the export price recorded a deep downturn. The most prominent rate of growth was recorded in 2021 an increase of X%. Over the period under review, the export prices reached the peak figure at $X per ton in 2012; however, from 2013 to 2022, the export prices remained at a lower figure.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was Kazakhstan ($X per ton), while Uzbekistan ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Uzbekistan (X%), while the other leaders experienced mixed trends in the export price figures.

Imports of Medicaments Containing Corticosteroid Hormones

Imports in CIS

In 2022, approx. X tons of medicaments containing corticosteroid hormones were imported in the CIS; with a decrease of X% compared with the year before. Total imports indicated a buoyant increase from 2012 to 2022: its volume increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, imports increased by X% against 2020 indices. The most prominent rate of growth was recorded in 2021 with an increase of X%. As a result, imports attained the peak of X tons, and then fell modestly in the following year.

In value terms, medicaments containing corticosteroid hormones imports fell notably to $X in 2022. Over the period under review, imports continue to indicate a relatively flat trend pattern. The most prominent rate of growth was recorded in 2021 when imports increased by X% against the previous year. The level of import peaked at $X in 2019; however, from 2020 to 2022, imports failed to regain momentum.

Imports by Country

Russia represented the largest importer of medicaments containing corticosteroid hormones in the CIS, with the volume of imports reaching X tons, which was approx. X% of total imports in 2022. Uzbekistan (X tons) took the second position in the ranking, followed by Kazakhstan (X tons). All these countries together took approx. X% share of total imports. Azerbaijan (X tons) and Kyrgyzstan (X tons) followed a long way behind the leaders.

Imports into Russia increased at an average annual rate of X% from 2012 to 2022. At the same time, Uzbekistan (X%), Azerbaijan (X%), Kazakhstan (X%) and Kyrgyzstan (X%) displayed positive paces of growth. Moreover, Uzbekistan emerged as the fastest-growing importer imported in the CIS, with a CAGR of X% from 2012-2022. While the share of Uzbekistan (X p.p.), Kazakhstan (X p.p.) and Azerbaijan (X p.p.) increased significantly in terms of the total imports from 2012-2022, the share of Russia (X p.p.) displayed negative dynamics. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Russia ($X) constitutes the largest market for imported medicaments containing corticosteroid hormones in the CIS, comprising X% of total imports. The second position in the ranking was held by Kazakhstan ($X), with a X% share of total imports. It was followed by Uzbekistan, with a X% share.

In Russia, medicaments containing corticosteroid hormones imports shrank by an average annual rate of X% over the period from 2012-2022. The remaining importing countries recorded the following average annual rates of imports growth: Kazakhstan (X% per year) and Uzbekistan (X% per year).

Import Prices by Country

The import price in the CIS stood at $X per ton in 2022, reducing by X% against the previous year. Over the period under review, the import price saw a abrupt decline. The most prominent rate of growth was recorded in 2019 an increase of X%. The level of import peaked at $X per ton in 2013; however, from 2014 to 2022, import prices remained at a lower figure.

There were significant differences in the average prices amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was Kazakhstan ($X per ton), while Kyrgyzstan ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Azerbaijan (X%), while the other leaders experienced mixed trends in the import price figures.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :